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We study patients with stenoses of the left main coronary artery (LMCA), left anterior descending artery (LAD), and left circumflex
branch (LCx) and with chronic occlusion of the right coronary artery (RCA), undergoing o-pump coronary surgery. An analog
electrical model is used to provide quantitative estimations of the distribution of flows and pressures across the coronary network
(in the stenosed native arteries, the collateral branches, the capillary areas, and so forth). The present paper demonstrates that
the clinical information collected for the 10 patients included in the study (Rentrop score, history of myocardial infarction, left
ventricular ejection fraction (LVEF)) are well correlated with the predicted hydrodynamic data. Patients with a good collaterality
(Rentrop score = 3) or patients without anterior myocardial infarction have (i) less severe stenoses on the LMCA, (ii) lower
microvascular resistances, (iii) higher grafts flow rates when the revascularization is performed, (iv) higher collateral flow rates
towards the territory of the occluded artery, (v) better perfusion of this area, and (vi) better total perfusion of the heart.
1. Introduction
In this work, we study patients with stenoses of the left main
coronary artery (LMCA), left anterior descending artery
(LAD), and left circumflex branch (LCx) and with chronic
occlusion of the right coronary artery (RCA), undergoing
o-pump coronary surgery. In this clinical situation, some
quantities of interest, for example, the collateral flows to the
occluded artery, are dicult to ascertain via preoperative
measurements. That is why we proposed in previously
published papers [1–3] a model of the coronary circulation
based on hydraulic/electric analogy. This model provides
quantitative estimations of the distribution of flows and
pressures across the coronary network (in the stenosed native
arteries, the collateral branches, the capillary areas, and so
forth). Complete simulation results have been published for
10 patients in Maasrani et al. [3]. The objective of the present
paper is to study how the clinical information collected
for these patients (Rentrop score, history of myocardial in-
farction, left ventricular ejection fraction (LVEF)) can be
correlated with the predicted hydrodynamic data. Such
relationships between qualitative or medical observations
and quantitative flows and pressures evaluations are lacking
at the time, and it is hoped that this study will augment the
surgeons’ professional experience.
2. Materials andMethods
2.1. Clinical Measurements for Each Patient. Informed,
signed consent was obtained from the patients before par-
ticipating in the study.
The reductions in diameter and area of the stenosed ar-
teries were estimated from angiographic observations, before
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Figure 1: Analog electrical model for the coronary network in case of stenoses on the LMCA, LAD, LCx, and chronic occlusion of the RCA
[2, 3]. The grafts are represented with dotted lines.
surgery. Collateral filling of the RCA was scored using the
Rentrop classification [4]: 0 = no filling; 1 = filling of the dis-
tal branches without visualization of its epicardial segment;
2 = partial filling of the epicardial segment; 3 = complete
filling of the epicardial segment via collateral vessels.
The o-pump coronary surgical procedure has been
described previously [5]. The RCA is first revascularized via
a saphenous vein graft. Two series of measurements are per-
formed: Pao (aortic pressure), Pv (central venous pressure),
Pw (pressure distal to the RCA occlusion), with the right graft
clamped (0G), and Pao, Pv, QRCAg (flow rate in the RCA graft)
with the right graft opened (1G). The left coronary arteries
are then revascularized via the internal thoracic arteries. Two
additional series of measurements are performed: Pao, Pv, Pw,
QLADg and QLCxg (flow rates in the LAD and LCx grafts) with
the right graft clamped (2G), and Pao, Pv, QLADg, QLCxg, and
QRCAg with the right graft opened (3G).
2.2. Simulations. The electrical analog model was first
presented in Maasrani et al. [1]. It has then been modified in
order to include possible stenosis on the LMCA and to take
into account variable stenosis coecients on all left branches
[2, 3]. It is shown in Figure 1.
Since the resistive eects are preponderant for small
diameter vessels, in this model, the capillaries are represented
by their hydraulic resistances (RLADc, RLCXc, and RRCAc are
the resistances of the capillaries vascularized by the LAD,
LCx, and RCA arteries, resp.). The blood flow rates across
the LAD, LCx, and RCA capillaries are denoted by QLADc,
QLCXc, and QRCAc, respectively. The collateral vessels are also
represented only by their resistances Rcoli, i = 1–5. Qcol1
and Qcol4 are the collateral flow rates from LAD towards
RCA (before and after LAD stenoses, resp.), Qcol2 and Qcol5
are the collateral flow rates from LCx (before and after LCx
stenoses, resp.) and Qcol3 is the collateral flow rate from the
aorta towards the RCA. Due to the diculty of determining
the exact characteristics of the collateral pathways, it was
assumed that all the collateral resistances are the same [1]:
Rcol1 = Rcol2 = Rcol3 = Rcol4 = Rcol5 = Rcol. The microvas-
cular resistances (RLADc, RLCxc, RRCAc, Rcol) are patient spe-
cific. Their determination is performed using the clinical
data measured during o-pump surgery (Section 2.1), as
explained in Maasrani et al. [2]. The other parameters of
the model (resistances, inductances, and compliances of
the left branches, of the RCA (distal to the thrombosis)
and of the grafts) are taken from the literature [6, 7]. The
influence of the stenoses on the LMCA, LAD and LCx is
also described according to Wang et al. [7]. The input of the
model is the aortic pressure wave, Pao(t), measured for each
patient and each situation (0G, 1G, 2G, 3G). The simulations
are performed with the Matlab Simulink program. The
calculated flows and pressures are time dependent, but,
since the influence of ventricular contraction upon coronary
vascular bed resistance is not taken into account in our
simulations at the time, we focus on average cardiac cycle
values. Besides, this is consistent with the fact that the
collected clinical data are also average cardiac cycle values.
2.3. Statistical Analysis. Our study includes only a small
number of patients (n = 10). Consequently, no reliable
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Table 1: Area reductions on the left branches, history of myocardial infarction, and LVEF (%): (a) Patients with Rentrop 3, (b) Patients with
Rentrop 1 and 2. No. Pat. in [3]: number of the patient in Maasrani et al. [3].
(a)
No. Pat. in [3]
Area reduc. LMCA
(%)
Area reduc. LAD
(%)
Area reduc. LCx
(%)
Mean reduc. all left
branches (%)
AMI? LVEF (%)
1 26 100 90 72 No 60
3 91.6 84.8 95.6 90.67 No 45
4 19 86 97 67.33 No 67
5 20 88 92 66.67 No 66
7 80 0 85 55 Yes 30
Mean ±σ R3 group 47.32± 35.47 71.76± 40.57 91.92 ± 4.77 70.33 ± 12.98 53.6 ± 15.85
(b)
No. Pat. in [3]
Area reduc. LMCA
(%)
Area reduc. LAD
(%)
Area reduc. LCx
(%)
Mean reduc. all left
branches (%)
AMI? LVEF (%)
2 46 89 95 76.67 Yes 57
6 85 94 82 87 No 46
8 87 70 90 82.33 Yes 60
9 83 78 0 53.67 No 60
10 75 93 0 56 Yes 30
Mean ±σ R1 and 2 group 75.2± 16.95 84.8± 10.43 53.4± 48.97 71.13± 15.34 50.6 ± 12.88
statistical tests can be presented. The results are expressed as
mean values ± standard deviation.
3. Results
The clinical measurements and the results of the simulations
for the 10 patients published in Maasrani et al. [3] are
analyzed according to two dierent classifications of the
patients: (i) in Section 3.1, group of patients with Rentrop
Score = 3 (“R3” group) versus group of patients with Rentrop
Score = 1 or 2 (“R1 and 2” group) and (ii) in Section 3.2,
group of patients with an anterior myocardial infarction
(“AMI” group) versus group of patients with no-AMI (“No-
AMI” group). For each group of patients, the measured area
reductions on the left branches, the calculated capillary and
collateral resistances, the measured flow rates in the grafts,
the predicted collateral flow rates, the predicted perfusion of
the right territory, and total coronary perfusion are analyzed
and compared.
3.1. Classification: “Rentrop 3” versus “Rentrop 1 and 2”.
According to the definition of the Rentrop Score, patients
with Rentrop 3 are expected to have a more ecient
collaterality than patients with Rentrop Score one or two
[8, 9].
3.1.1. Severity of the Coronary Disease. The clinical data
for our ten patients are presented in Tables 1(a) and 1(b).
The “mean reduction on all left branches” is defined as
(area reduction on LMCA + area reduction on LAD + area
reduction on LCx)/3.
Lesions on LMCA are less severe in the “R3” group:
47.32% ± 35.47 versus 75.2% ± 16.95 in the “R1 and 2”
group. In the absence of the left grafts, a less obstructed
LMCA will facilitate the LAD and LCx flows, and conse-
quently, the collateral flows.
If one considers only the patients who have lesions on the
LAD or on the LCx artery, no significant dierence between
the two groups can be demonstrated: mean value for the
patients who have lesions on the LAD branch in the “R3”
group = (100 + 84.8 + 86 + 88)/4 = 89.7% ± 7.0, compared to
the mean area reduction of the LAD branch in the “R1 and 2”
group (84.8% ± 10.43), and mean value for the patients who
have lesions on the LCx branch in the “R1 and 2” group =
(95 + 82 + 90)/3 = 89% ± 6.56, compared to the mean area
reduction of the LCx branch in the “R3” group (91.92% ±
4.77).
Mean reductions of area for all left branches together are
similar in the two groups: 70.33% ± 12.98 for the “R3” group
and 71.13% ± 15.34 for the “R1 and 2” group.
A majority of patients of the “R3” group did not have an
AMI, except Patient 7. On the contrary, Patients 6 and 9 have
a Rentrop Score = 1 or 2 and did not have an AMI. Patients
with better collateral flow grades were more likely to have
higher LVEF. This bears out similar observations by previous
authors [9, 10].
3.1.2. Capillary and Collateral Resistances. The values of
the calculated capillary and collateral resistances for the 10
patients are presented in Tables 2(a) and 2(b). The mean
capillary resistance, Rcapmean, is defined as Rcapmean = (RLADc+
RLCxc + RRCAc)/3.
Except for the RLCxc value (i.e., comparable in the
“R3” and “R1 and 2” groups), all the other microvascular
resistances are significantly lower in the “R3” group. The pro-
portion between the right capillary resistance, RRCAc, and the
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Table 2: Capillary and collateral resistances values (mmHg·s/mL): (a) Patients with Rentrop 3, (b) Patients with Rentrop 1 and 2.
(a)
No. Pat. in [3] RLADc RLCxc RRCAc Rcol Rcapmean RRCAc/Rcapmean
1 83.3 207.9 54.1 160 115.1 0.47
3 213 94.2 62.8 350 123.33 0.51
4 47.5 119.1 147.2 565 104.6 1.41
5 175.3 68.7 56.1 205 100.03 0.56
7 50.2 118.4 76 650 81.53 0.93
Mean ±σ R3 group 113.86±75.82 121.66±52.47 79.24± 38.94 386± 216.14 104.92±15.92 0.77± 0.4
(b)
No. Pat. in [3] RLADc RLCxc RRCAc Rcol Rcapmean RRCAc/Rcapmean
2 174.6 210.9 96.9 430 160.8 0.6
6 240.4 135.5 117.6 1055 164.5 0.71
8 77.6 196 347.6 970 207.06 1.68
9 374.8 33.7 80.7 420 163.07 0.49
10 155.9 62.1 213.8 405 143.93 1.485
Mean ±σ R1 and 2 group 204.66±111.41 127.64±78.72 171.32±111.26 656±326.94 167.87±23.42 0.993± 0.55
other capillary resistances, Rcapmean, is also lower in the “R3”
group. This seems quite logical: lower collateral and right
capillary resistances will facilitate the collateral flows [11, 12].
Looking patient by patient, it can be noticed from the
data of Tables 1(a), 1(b), 2(a), and 2(b) that the less severe
mean artery lesions (mean reduction all left branches) are
generally associated with lower microvascular resistances.
It can be also noticed that low distal capillary resistances
are obtained for the nonstenosed arteries. Such a trend was
previously demonstrated by Chamuleau et al. [13]. These
authors found an association between coronary lesion sever-
ity and the resistance of the downstream microcirculation
assessed by intracoronary-derived pressure and Doppler flow
velocity measurement. They also demonstrated that minimal
microvascular resistance is higher distal to hemodynamically
significant stenosis compared with vessels without stenosis
in the same patient. This relationship is not so evident in our
study because of the existence of multiple artery lesions and
of the confounding eect of collateral flow.
3.1.3. Measured Flow Rates in the Grafts, in the Case (2G)
(Right Graft Clamped) and (3G) (Right Graft Unclamped).
These data are presented in Tables 3(a) and 3(b).
The flow rates in the grafts are much higher in the
“R3” group, probably because the microvascular resistances
are smaller. As demonstrated by many authors [14–18], the
status of the distal supplied territory influences the flow in
the graft.
3.1.4. Simulated Collateral Flow Rates, in the Cases (0G) and
(2G). The collateral flow rates in the case (0G) (resp., (2G))
are presented in Tables 4(a) and 4(b) (resp., Tables 5(a)
and 5(b)). Qcoltotal represents the sum of all collateral flows
(Qcol1 + Qcol2 + Qcol3 + Qcol4 + Qcol5). By construction of our
model (Figure 1), PM − Pw = Rcol1 ∗ Qcol1 = Rcol2 ∗ Qcol2.
Since Rcol1 = Rcol2, Qcol1 = Qcol2.
In the case (0G), the predicted collateral flow rates, Qcol1,
Qcol2, Qcol3, and Qcoltotal, are higher in the “R3” group. This is
related to less severe LMCA stenoses and lower collateral and
right capillary resistances for the patients of this group. Some
negative collateral flow rates (from the right branch to a left
branch) may occur if one of the left branches has a very severe
stenosis (e.g., this is the case of Patient 1 whose LAD is almost
totally obstructed). Such an inversion of collateral flow has
previously been shown in the literature, due to an inversion
of the pressure gradient across the collateral network [19].
Although the influence of collateral flows remains moderate,
it may substantially influence the occurrence of ischemia in
the right distal territory. Other studies also reached the same
conclusion and established that angiographical presence of
collaterals is a clinically relevant prognostic factor [8, 9, 20].
In the case (2G), higher collateral flow rates are also
found for the patients of the group “R3.” As previously
shown [1–3], the left grafts do not really improve the
collateral flows (comparison of the case (2G) with the
pathological situation (0G)).
3.1.5. Simulated Flow Rates towards the Right Capillary Area
QRCAc. These flow rates are presented in Tables 6(a) and
6(b), for the four revascularization situations considered in
this study.
Patients of the group “R3” show a quite better perfu-
sion of the right-sided myocardial territories, in all cases,
due to lower Rcol and RRCAc resistances. As explained in
Section 3.1.4, the presence of the left grafts does not induce
a significant improvement of the perfusion of the right ter-
ritory (situation (2G) compared to situation (0G)). Such an
improvement is obtained when the right graft is operating.
3.1.6. Simulated Total Coronary Flow Rate Qt . Qt represents
the sum of the flow rates in the LAD branch, LCx and RCA
branch. Its values are given in Tables 7(a) and 7(b), for
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Table 3: Measured flow rates (mL/min) in the grafts, in the case (2G) and (3G): (a) Patients with Rentrop 3, (b) Patients with Rentrop 1 and
2.
(a)
No. Pat. in [3] QLADg(2G) QLCxg(2G) QLADg(3G) QLCxg(3G) QRCAg(3G)
1 34 27 40 14 66
3 22 48 19 45 74
4 59 40 57 30 26
5 24 56 18 46 69
7 28 43 28 29 51
Mean ±σ R3 group 33.4± 15.03 42.8± 10.71 32.4± 16.35 32.8± 13.22 57.2± 19.43
(b)
No. Pat. in [3] QLADg(2G) QLCxg(2G) QLADg(3G) QLCxg(3G) QRCAg(3G)
2 23 32 21 19 45
6 11 12 14 18 30
8 38 16 28 17 10
9 24 60 23 45 51
10 20 7 18 13 14
Mean ±σ R1 and 2 group 23.2± 9.73 25.4± 21.49 20.8± 5.26 22.4± 12.84 30± 18.18
Table 4: Simulated collateral flow rates (mL/min) in the case (0G): (a) Patients with Rentrop 3, (b) Patients with Rentrop 1 and 2.
(a)
No. Pat. in [3] Qcol1 Qcol3 Qcol4 Qcol5 Qcoltotal
1 10.6 10.7 −7.0 6.6 31.5
3 6.2 8.9 4.9 −0.4 25.8
4 3.9 3.9 1.5 −1.2 12
5 10.4 10.5 6.2 1.5 39
7 3.6 4.3 3.6 3.0 18.1
Mean ±σ R3 group 6.94± 3.4 7.66± 3.33 1.84± 5.24 1.9± 3.1 25.28± 10.67
(b)
No. Pat. in [3] Qcol1 Qcol3 Qcol4 Qcol5 Qcoltotal
2 5.6 5.7 3.3 1.8 22
6 2.5 2.8 1.1 2.3 11.2
8 1.4 1.9 1.2 0.9 6.8
9 3.4 4.6 3.1 3.3 17.8
10 2.5 2.8 −0.4 2.4 9.8
Mean ±σ R1 and 2 group 3.08± 1.58 3.56± 1.55 1.66± 1.54 2.14± 0.88 13.52±6.22
the four revascularization situations ((0G), (1G), (2G), and
(3G)).
The results obtained for the total coronary flow, Qt,
are quite consistent with the other results of this paper:
patients of the group “R3” have higher collateral flow rates,
higher grafts flow rates, lower microvascular resistances,
and so forth. Consequently, the values of Qt for these
patients are also higher than for the patients of the “R1
and 2” group. The results of Tables 7(a) and 7(b) are also
consistent with the results of theoretical simulations that
we previously published to see the impact of capillary and
collateral resistances on the total coronary flow rate Qt (see
[1, Figures 5 and 6]). These simulations have shown that
Qt is improved when the capillary resistances and/or the
collateral resistances are decreased.
3.2. Classification “AMI” versus “No-AMI”. The objective of
this classification of the patients was to test if the history
of myocardial infarction was associated with a less ecient
collaterality and impaired microvascular resistances. Indeed,
it is well accepted that destruction of the morphologic
integrity and scar formation of the myocardium as caused
by myocardial infarction negatively aects the coronary
microcirculation. Although the presence of microvascular
injury can be assessed with several invasive and noninvasive
techniques [21], this assessment remains challenging.
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Table 5: Simulated collateral flow rates (mL/min) in the case (2G): (a) Patients with Rentrop 3, (b) Patients with Rentrop 1 and 2.
(a)
No. Pat. in [3] Qcol1 Qcol3 Qcol4 Qcol5 Qcoltotal
1 7.4 7.4 5.8 6.7 34.7
3 6.2 6.9 6.3 5.9 31.5
4 2.8 2.8 2.2 2.5 13.1
5 7.4 7.4 6.7 5.9 34.8
7 4.1 4.4 4.0 4.0 20.6
Mean ±σ R3 group 5.58± 2.06 5.78± 2.08 5.0± 1.87 5.0± 1.71 26.94±9.68
(b)
No. Pat. in [3] Qcol1 Qcol3 Qcol4 Qcol5 Qcoltotal
2 4.6 4.6 4.2 4.3 22.3
6 2.3 2.4 2.3 2.2 11.5
8 1.3 1.5 1.2 1.3 6.6
9 3.7 4.3 3.9 3.7 19.3
10 2.1 2.4 2.0 2.1 10.7
Mean ±σ R1 and 2 group 2.8± 1.33 3.04± 1.34 2.72± 1.28 2.72± 1.24 14.08± 6.5
Table 6: Simulated flow rates towards the right capillary area, QRCAc (mL/min): (a) Patients with Rentrop 3, (b) Patients with Rentrop 1 and
2.
(a)
No. Pat. in [3] QRCAc(0G) QRCAc(1G) QRCAc(2G) QRCAc(3G)
1 31.5 70.3 34.6 66
3 25.8 73.9 31.6 74
4 11.9 28 13.2 26
5 38.8 75.3 34.9 68.9
7 18.1 53.4 20.7 51
Mean ±σ R3 group 25.22± 10.63 60.18± 20.0 27± 9.64 57.18± 19.42
(b)
No. Pat. in [3] QRCAc(0G) QRCAc(1G) QRCAc(2G) QRCAc(3G)
2 21.9 47.4 22.3 45
6 11.3 30 11.4 30
8 6.7 12.1 6.6 10
9 17.7 41.4 19.3 51
10 9.8 15.1 10.7 14
Mean ±σ R1 and 2 group 13.48± 6.18 29.2± 15.59 14.06± 6.5 30± 18.18
The group of patients who had an AMI includes patients
no. 2, 7, 8, 10 (n = 4 patients); the group of patients who
did not have an AMI includes patients no. 1, 3, 4, 5, 6, and
9 (n = 6 patients). The detailed data for these patients have
been already recalled in Section 3.1; consequently, only the
mean values for the two groups are given here, for the sake of
comparison.
3.2.1. Severity of the Coronary Disease. Table 8 presents the
mean values of area reductions on the left branches, Rentrop
scores and LVEF, for the “AMI” group compared to those of
the “No-AMI” group.
Patients of the group “AMI” have more severe stenoses
on the LMCA branch than patients of the group “no-AMI”
(72% ± 18 versus 54.1% ± 35.7). Considering the patients
who have stenoses on the LAD and on the LCx branch, no
significant dierences appear in the mean severity of the
stenoses between the two groups: mean area reduction for
the patients who have stenoses on the LAD in the “AMI”
group = (89 + 70 + 93)/3 = 84%±12.3 versus 88.47%±7.65
in the “No-AMI” group, and mean area reduction for the
patients who have stenoses on the LCx in the “No-AMI”
group = (90 + 95.6 + 97 + 92 + 82)/5 = 91.32%± 5.91 versus
(95 + 85 + 90)/3 = 90%± 5 in the “AMI” group. Collaterality
(Rentrop Score) is better for the group “No-AMI” and is
associated with a less severe deterioration of the left ventric-
ular ejection fraction. This result is quite consistent with that
of Bexell et al. [22] who demonstrate a relationship between
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Table 7: Simulated total coronary flow rates, Qt (mL/min): (a) Patients with Rentrop 3, (b) Patients with Rentrop 1 and 2.
(a)
No. Pat. in [3] Qt(0G) Qt(1G) Qt(2G) Qt(3G)
1 51.9 102.2 82.3 122.9
3 57.1 113.3 94.5 141.9
4 75.8 98.7 108.1 129.4
5 94.5 135.3 100.2 142.8
7 120.2 155.6 139.9 156.4
Mean ±σ R3 group 79.9± 28.1 121.02±24.04 105± 21.66 138.68±13.00
(b)
No. Pat. in [3] Qt(0G) Qt(1G) Qt(2G) Qt(3G)
2 55.9 84.5 64.1 89.4
6 49.3 62.5 54.2 69.6
8 67.7 74.2 70.2 69.7
9 108.8 134.9 119.6 175.7
10 71.7 78.5 81.2 79.4
Mean ±σ R1 and 2 group 70.68± 23.12 86.92± 28.0 77.86± 25.3 96.76± 44.88
Table 8: Area reductions on the left branches, Rentrop Score, and LVEF (%): mean values of the group “AMI” compared to those of the
group “No-AMI.”
Area reduc. LMCA
(%)
Area reduc. LAD
(%)
Area reduc. LCx
(%)
Mean reduc. all
left branches
Rentrop score LVEF (%)
Mean ±σ “AMI” group 72± 18 63± 43.2 67.5± 45.2 67.5± 14.05 2± 0.8 44.25± 16.5
Mean ±σ “No-AMI” group 54.1± 35.7 88.47± 7.65 76.13± 37.67 72.89± 13.84 2.5± 0.84 57.33± 9.63
coronary artery lesion severity, extent of collateralization,
and importance of the microvascular damages.
3.2.2. Capillary and Collateral Resistances. The mean values
of the capillary and collateral resistances are given in Table 9,
for the “AMI” group, compared to those of the “No-AMI”
group.
As expected, most of the microvascular resistances (RLCxc,
RRCAc, Rcol, Rcapmean) are lower in the group “No-AMI” than
in the group “AMI.” The proportion between the RRCAc
and the other capillary resistances, RRCAc/Rcapmean, is also
lower. It has been demonstrated by several authors that acute
myocardial infarction can be associated with the presence of
microvascular obstruction [21, 23], which would of course
induce an increase in capillary vascular resistances. In a
somewhat dierent study (balloon angioplasty in patients
with one-vessel disease), Van Liebergen et al. [24] also found
that the collateral resistance and the peripheral resistance
of the recipient coronary artery are lower in the group
of patients without ischemia compared to the group with
ischemia. Unfortunately, their data are expressed in units that
cannot be directly compared to ours.
We note that the mean value of RLADc in the “AMI group”
is influenced by Patient 7, who does not have any stenosis on
the LAD branch, and who presents a low value of RLADc.
3.2.3. Measured Flow Rates in the Grafts, in the Case (2G)
(Right Graft Clamped) and (3G) (Right Graft Unclamped). As
shown in Table 10, there is no important dierence in the
LAD graft flow rates between the 2 groups (“AMI” and “No-
AMI”). But there is a significative dierence in the LCx graft
flow rates: they are much higher in the “No-AMI” group
(40.5 mL/min ± 18.28 in the case (2G) and 33 mL/min ±
14.5 in the case (3G)) than in the “AMI” group (24.5 mL/min
± 16.1 in the case (2G) and 19.5 mL/min ± 6.8 in the case
(3G)). The flow rates in the right graft are also much higher
for the patients who did not have an AMI. As explained
in Section 3.1.3, this could be related to the fact that the
resistances of the distal perfused territories, RLCxc and RRCAc,
are lower for this group of patients. Spies et al. [15] also
found that flow reserve is reduced in bypasses supplying
infarcted myocardium, likely due to altered microcirculation.
3.2.4. Simulated Collateral Flow Rates, in the Cases (0G) and
(2G). The mean values of the simulated collateral flow rates
in the case (0G) (resp., (2G)) for the two groups of patients
are presented in Table 11 (resp., Table 12).
As can be seen in Table 11, the collateral flows Qcol1 and
Qcol2 are higher for the patients of the “No-AMI” group. This
may be related to the fact that patients of this group have less
severe stenoses on the LMCA. The total collateral flows are
also higher for these patients, which is consistent with the
fact that their Rcol and RRCAc are lower than for the patients
who had an AMI. Our data thus support the observation
made by many authors (e.g., Levin [25]) that well-developed
collaterals exert a beneficial eect on myocardial viability and
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Table 9: Capillary and collateral resistances values (mmHg·s/mL): mean values of the group “AMI” compared to those of the group “No-
AMI.”
RLADc RLCxc RRCAc Rcol Rcapmean RRCAc/Rcapmean
Mean ±σ “AMI” group 114.57± 60.06 146.85± 69.55 183.57± 125.04 613.75± 261.77 148.3± 51.9 1.17± 0.49
Mean ±σ “No-AMI” group 189.05± 117.58 109.85± 60.16 86.42± 38.0 459.17± 326.73 128.44± 28.56 0.69± 0.36
Table 10: Measured flow rates (mL/min) in the grafts, in the case (2G) and (3G): mean values of the group “AMI” compared to those of the
group “No-AMI.”
QLADg(2G) QLCxg(2G) QLADg(3G) QLCxg(3G) QRCAg(3G)
Mean ±σ “AMI” group 27.25± 7.89 24.5± 16.1 23.75± 5.06 19.5± 6.8 30± 21.0
Mean ±σ “No-AMI” group 29± 16.42 40.5± 18.28 28.5± 16.65 33± 14.5 52.67± 20.63
Table 11: Simulated collateral flow rates (mL/min) in the case (0G): mean values of the group “AMI” compared to those of the group
“No-AMI.”
Qcol1 Qcol3 Qcol4 Qcol5 Qcoltotal
Mean ±σ “AMI” group 3.27± 1.79 3.67± 1.67 1.92± 1.88 2.02± 0.89 14.17± 7.07
Mean ±σ “No-AMI” group 6.17± 3.57 6.9± 3.53 1.63± 4.66 2.02± 2.8 22.88± 11.16
Table 12: Simulated collateral flow rates (mL/min) in the case (2G): mean values of the group “AMI” compared to those of the group
“No-AMI.”
Qcol1 Qcol3 Qcol4 Qcol5 Qcoltotal
Mean ±σ “AMI” group 3.02± 1.58 3.22± 1.52 2.85± 1.48 2.92± 1.46 15.05± 7.61
Mean ±σ “No-AMI” group 4.97± 2.31 5.2± 2.32 4.53± 2.01 4.48± 1.93 24.15± 10.81
ventricular function after acute coronary occlusion. They
may prevent ischemic cardiac events [26].
As found in the case (0G), in the case (2G), the collateral
flows in the group “No-AMI” are higher than in the group
“AMI” (Table 12). As explained in Section 3.1.4, the presence
of the left grafts does not induce a significant improvement
of the collateral flows.
3.2.5. Simulated Flow Rates towards the Right Capillary
Area QRCAc. These values are presented in Table 13, for the
two groups of patients and for the four revascularization
situations.
In all cases, the perfusion of the right capillary territory,
QRCAc, is better in the “No-AMI” group, due to higher
collateral flow rates and lower microvascular resistances. As
explained by Nijveldt et al. [21], despite successful recanal-
ization of the infarct-related artery (which corresponds to
the cases (1G) and (3G) in our study), in patients with
AMI, perfusion of the ischemic myocardium may not be
completely restored due to microvascular obstruction.
3.2.6. Simulated Total Coronary Flow Rates Qt. The mean
values of Qt for the two groups of patients and the four
revascularization situations are given in Table 14.
In the cases (1G), (2G), and (3G), the total coronary
perfusion, Qt, is higher for the “No-AMI” group. This is a
logical consequence of the previous results (Sections 3.2.1 to
3.2.5). The results obtained in the case (0G) may be related
to the influence of the LAD branch; as shown in Table 9,
the distal capillary resistance of this branch was found to be
higher in the “No-AMI” group than in the “AMI” group.
4. Discussion
The range of values of the hydrodynamic data (resistances,
flow rates, and so forth) obtained in our study has been
discussed in detail in Maasrani et al. [1]. The agreement with
the literature is good. It is hoped that such data can help
the cardiologists and cardiac surgeons in decision-making
process.
It can be seen from Tables 3(a), 3(b), and 10 that a
decrease in blood flow occurs across the LAD graft, ∆QLADg,
and across the LCx graft, ∆QLCxg, after unclamping the
saphenous vein graft implanted on the occluded RCA.
∆QLADg is thus defined as ∆QLADg = QLADg(2G)−QLADg(3G)
and ∆QLCxg as ∆QLCxg = QLCxg(2G) − QLCxg(3G). The mean
values of these quantities are reported in Table 15, for the
four groups of patients considered in this study; they are
in the range of a few mL/min. These results confirm the
observations we made in a previous paper [27].
In the situation (3G), all the grafts are operating and the
role of collaterality becomes negligible (because the pressure
gradient across the collateral network drops to almost zero)
[1, 3, 28]. The drops in the grafts ∆QLADg and ∆QLCxg
may thus represent the amount of collateral blood flow
contributed by the left grafts in the situation (2G). It is
interesting to note that these values fall exactly in the same
range (<10 mL/min) as the simulated collateral flows, Qcol1,
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Table 13: Simulated flow rates (mL/min) towards the right capillary area, QRCAc: mean values of the group “AMI” compared to those of the
group “No-AMI.”
QRCAc(0G) QRCAc(1G) QRCAc(2G) QRCAc(3G)
Mean ±σ “AMI” group 14.12± 7.07 32± 21.42 15.07± 7.63 30± 21
Mean ±σ “No-AMI” group 22.83± 11.11 53.15± 22.46 24.17± 10.83 52.65± 20.61
Table 14: Simulated total coronary flow rates (mL/min), Qt : mean values of the group “AMI” compared to those of the group “No-AMI.”
Qt(0G) Qt(1G) Qt(2G) Qt(3G)
Mean ±σ “AMI” group 78.87± 28.35 98.2± 38.5 88.85± 34.76 98.72± 39.28
Mean ±σ “No-AMI” group 72.9± 24.54 107.82± 27.15 93.15± 22.84 130.38± 34.9
Table 15: Drops in the left grafts flow rates (mL/min) after unclamping the RCA graft; mean values for the four groups of patients considered
in this study.
“R3” group “R1 and 2” group “AMI” group “No-AMI” group
∆QLADg 1± 4.47 2.4± 4.72 3.5± 4.43 0.5± 4.32
∆QLCxg 10± 4.3 3± 10.27 5± 10.03 7.5± 7.76
Qcol2, Qcol4, and Qcol5, presented in Tables 5(a), 5(b), and
12, the total collateral flow from LAD to RCA being Qcol1 +
Qcol4, and the total collateral flow from LCx to RCA being
Qcol2 + Qcol5 (see Figure 1). However, it appears from the
measurements of Table 15 that the main decrease in flow rate
occurs across the LCx graft. At the time, our model (Figure 1)
does not take into account such a dissymmetry between
the LAD side and the LCx side, because of the simplifying
assumption that all the collateral resistances, Rcoli, are the
same. Improving the representation of the collateral vessels
(using, e.g., some proportionality coecients between the
dierent Rcoli values, and/or using the data provided by
Rockstroh and Brown [12]) would certainly improve the
physiological relevance of the model.
5. Conclusion
It is demonstrated in this study that patients with a
good collaterality (Rentrop Score = 3) or patients without
anterior myocardial infarction (No-AMI) have (i) less severe
stenoses on the LMCA, (ii) lower microvascular resistances,
(iii) higher grafts flow rates when the revascularization is
performed, (iv) higher collateral flow rates towards the
territory of the occluded artery, (v) better perfusion of this
area, and (vi) better total perfusion of the heart.
The present study thus emphasizes the relevance of
the hemodynamic variables for evaluation of the collateral
eciency and microvascular damages in patients with three-
vessel disease and total obstruction of the RCA.
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